DMII · Company research
Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| DMII 8-K & SEC Filings - Yahoo Finance Australia | DMII 8-K & SEC Filings Yahoo Finance Australia | View source ↗ | Yahoo Finance Australia | Oct 8, 2026 | neutral | 0 | 0.6 |
| DMII Holds Flat at $10.19 as Blank-Check Shares Trade Near Trust Value - Cash Flow Strong Stocks - https://www.dars.gov.et/ | DMII Holds Flat at $10.19 as Blank-Check Shares Trade Near Trust Value - Cash Flow Strong Stocks https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 6, 2026 | neutral | 0 | 0.6 |
| Drugs (DMII) Stock Alert: Dead Money at $10.16 — Or Is It? 2026-09-17 - Throwback Trade - dars.gov.et | Drugs (DMII) Stock Alert: Dead Money at $10.16 — Or Is It? 2026-09-17 - Throwback Trade dars.gov.et | View source ↗ | dars.gov.et | Sep 17, 2026 | neutral | 0 | 0.6 |
| Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within Range - Value Area Low - dars.gov.et | Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within Range - Value Area Low dars.gov.et | View source ↗ | dars.gov.et | Sep 2, 2026 | neutral | 0 | 0.6 |
| Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within Range - ETF Inflow Streak - www.dars.gov.et | Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within Range - ETF Inflow Streak www.dars.gov.et | View source ↗ | www.dars.gov.et | Sep 2, 2026 | neutral | 0 | 0.6 |
| Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest Session - Schiff Line - https://www.dars.gov.et/ | Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest Session - Schiff Line https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Aug 20, 2026 | neutral | 0 | 0.6 |
| Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest Trading - RVOL Breakout - dars.gov.et | Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest Trading - RVOL Breakout dars.gov.et | View source ↗ | dars.gov.et | Aug 20, 2026 | neutral | 0 | 0.6 |
| Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest Session - Earnings Miss Risk - www.dars.gov.et | Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest Session - Earnings Miss Risk www.dars.gov.et | View source ↗ | www.dars.gov.et | Aug 20, 2026 | neutral | 0 | 0.6 |
| EHC Q2 2026 Earnings: EPS Beats Estimates by 3.72% as Stock Slips 1.29% - Earnings Trend Analysis - https://www.dars.gov.et/ | EHC Q2 2026 Earnings: EPS Beats Estimates by 3.72% as Stock Slips 1.29% - Earnings Trend Analysis https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Aug 17, 2026 | neutral | 0 | 0.6 |
| DMII Holds Steady at $10.13 as Acquisition Vehicle Trades in Tight Range - MA Cross Alert - dars.gov.et | DMII Holds Steady at $10.13 as Acquisition Vehicle Trades in Tight Range - MA Cross Alert dars.gov.et | View source ↗ | dars.gov.et | Aug 14, 2026 | neutral | 0 | 0.6 |
| Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ: DMII) Stock Price, News & Analysis - kalkine.ca | Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ: DMII) Stock Price, News & Analysis kalkine.ca | View source ↗ | kalkine.ca | Apr 23, 2026 | neutral | 0 | 0.6 |
| DMII (NASDAQ: DMII) files 12b-25—expects to file 10-K by Apr 15, 2026 - Stock Titan | DMII (NASDAQ: DMII) files 12b-25—expects to file 10-K by Apr 15, 2026 Stock Titan | View source ↗ | Stock Titan | Apr 1, 2026 | neutral | 0 | 0.6 |
| Drugs Made In America Acquisition II (DMII) Stock Chart and Price History 2026 - MarketBeat | Drugs Made In America Acquisition II (DMII) Stock Chart and Price History 2026 MarketBeat | View source ↗ | MarketBeat | Jan 28, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Dec 4, 2025 | neutral | 0 | 0.6 |
| DMII Stock Price and Chart — NASDAQ:DMII - TradingView | DMII Stock Price and Chart — NASDAQ:DMII TradingView | View source ↗ | TradingView | Dec 3, 2025 | neutral | 0 | 0.6 |
| Families of Trump and commerce secretary stand to benefit from U.S. drug overhaul: WSJ - Seeking Alpha | Families of Trump and commerce secretary stand to benefit from U.S. drug overhaul: WSJ Seeking Alpha | View source ↗ | Seeking Alpha | Oct 8, 2025 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.